Cargando…

Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood

INTRODUCTION: We describe the natural history of patients with a Zellweger spectrum disorder (ZSD) surviving into adulthood. METHODS: Retrospective cohort study in patients with a genetically confirmed ZSD. RESULTS: All patients (n = 19; aged 16–35 years) had a follow-up period of 1–24.4 years (mean...

Descripción completa

Detalles Bibliográficos
Autores principales: Berendse, Kevin, Engelen, Marc, Ferdinandusse, Sacha, Majoie, Charles B. L. M., Waterham, Hans R., Vaz, Frédéric M., Koelman, Johannes H. T. M., Barth, Peter G., Wanders, Ronald J. A., Poll-The, Bwee Tien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710674/
https://www.ncbi.nlm.nih.gov/pubmed/26287655
http://dx.doi.org/10.1007/s10545-015-9880-2
_version_ 1782409839459172352
author Berendse, Kevin
Engelen, Marc
Ferdinandusse, Sacha
Majoie, Charles B. L. M.
Waterham, Hans R.
Vaz, Frédéric M.
Koelman, Johannes H. T. M.
Barth, Peter G.
Wanders, Ronald J. A.
Poll-The, Bwee Tien
author_facet Berendse, Kevin
Engelen, Marc
Ferdinandusse, Sacha
Majoie, Charles B. L. M.
Waterham, Hans R.
Vaz, Frédéric M.
Koelman, Johannes H. T. M.
Barth, Peter G.
Wanders, Ronald J. A.
Poll-The, Bwee Tien
author_sort Berendse, Kevin
collection PubMed
description INTRODUCTION: We describe the natural history of patients with a Zellweger spectrum disorder (ZSD) surviving into adulthood. METHODS: Retrospective cohort study in patients with a genetically confirmed ZSD. RESULTS: All patients (n = 19; aged 16–35 years) had a follow-up period of 1–24.4 years (mean 16 years). Seven patients had a progressive disease course, while 12 remained clinically stable during follow-up. Disease progression usually manifests in adolescence as a gait disorder, caused by central and/or peripheral nervous system involvement. Nine were capable of living a partly independent life with supported employment. Systematic MRI review revealed T2 hyperintense white matter abnormalities in the hilus of the dentate nucleus and/or peridentate region in nine out of 16 patients. Biochemical analyses in blood showed abnormal peroxisomal biomarkers in all patients in infancy and childhood, whereas in adolescence/adulthood we observed normalization of some metabolites. CONCLUSIONS: The patients described here represent a distinct subgroup within the ZSDs who survive into adulthood. Most remain stable over many years. Disease progression may occur and is mainly due to cerebral and cerebellar white matter abnormalities, and peripheral neuropathy.
format Online
Article
Text
id pubmed-4710674
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-47106742016-01-19 Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood Berendse, Kevin Engelen, Marc Ferdinandusse, Sacha Majoie, Charles B. L. M. Waterham, Hans R. Vaz, Frédéric M. Koelman, Johannes H. T. M. Barth, Peter G. Wanders, Ronald J. A. Poll-The, Bwee Tien J Inherit Metab Dis Original Article INTRODUCTION: We describe the natural history of patients with a Zellweger spectrum disorder (ZSD) surviving into adulthood. METHODS: Retrospective cohort study in patients with a genetically confirmed ZSD. RESULTS: All patients (n = 19; aged 16–35 years) had a follow-up period of 1–24.4 years (mean 16 years). Seven patients had a progressive disease course, while 12 remained clinically stable during follow-up. Disease progression usually manifests in adolescence as a gait disorder, caused by central and/or peripheral nervous system involvement. Nine were capable of living a partly independent life with supported employment. Systematic MRI review revealed T2 hyperintense white matter abnormalities in the hilus of the dentate nucleus and/or peridentate region in nine out of 16 patients. Biochemical analyses in blood showed abnormal peroxisomal biomarkers in all patients in infancy and childhood, whereas in adolescence/adulthood we observed normalization of some metabolites. CONCLUSIONS: The patients described here represent a distinct subgroup within the ZSDs who survive into adulthood. Most remain stable over many years. Disease progression may occur and is mainly due to cerebral and cerebellar white matter abnormalities, and peripheral neuropathy. Springer Netherlands 2015-08-19 2016 /pmc/articles/PMC4710674/ /pubmed/26287655 http://dx.doi.org/10.1007/s10545-015-9880-2 Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Berendse, Kevin
Engelen, Marc
Ferdinandusse, Sacha
Majoie, Charles B. L. M.
Waterham, Hans R.
Vaz, Frédéric M.
Koelman, Johannes H. T. M.
Barth, Peter G.
Wanders, Ronald J. A.
Poll-The, Bwee Tien
Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood
title Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood
title_full Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood
title_fullStr Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood
title_full_unstemmed Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood
title_short Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood
title_sort zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710674/
https://www.ncbi.nlm.nih.gov/pubmed/26287655
http://dx.doi.org/10.1007/s10545-015-9880-2
work_keys_str_mv AT berendsekevin zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood
AT engelenmarc zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood
AT ferdinandussesacha zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood
AT majoiecharlesblm zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood
AT waterhamhansr zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood
AT vazfredericm zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood
AT koelmanjohanneshtm zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood
AT barthpeterg zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood
AT wandersronaldja zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood
AT pollthebweetien zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood